NatureWise Biotech & Medicals Common Stock

NatureWise Biotech & Medicals (4732.TWO) currently reports a common stock of $490M as of June 2026. That compares with $490M in the prior-year period — up 0.2% year over year. Use the charts on this page to explore NatureWise Biotech & Medicals's common stock history and peer comparisons.

NatureWise Biotech & Medicals's common stock increased from $490M to $490M — a 0.2% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NatureWise Biotech & Medicals reported $490M in common stock as of June 2026. That compares with $490M in the prior-year period — up 0.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $490M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for NatureWise Biotech & Medicals, and consider following 4732.TWO for alerts when major investors trade the stock.

NatureWise Biotech & Medicals is classified in the Healthcare sector. On common stock, it currently shows $490M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 4732.TWO with unrelated industries.